The purpose of this study is to demonstrate improved pain control and outcomes in wrist operations with the use of a long-acting local anesthetic, EXPAREL, when compared to the use of the standard local anesthetic, Marcaine.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
70
EXPAREL arm: one vial (266 mg/20 mL) of EXPAREL (Bupivicaine Extended-Release Liposome, 13.3mg/ml), undiluted, will be administered for each of the specified procedures.
15 cc of Marcaine 0.5% (Bupivacaine 0.5%, 5mg/ml) will be administered into the wrist per the Surgeon's Standard practice.
UTCOM Chattanooga Department of Plastic Surgery
Chattanooga, Tennessee, United States
Changes in Pain
Pain measured by Numeric Rating Scale (NRS)
Time frame: Pre-op, Post-op days: 1,2,3,4, and 14
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.